%D8%A3%D9%83%D8%B1%D9%88%D9%84%D9%8A%D9%86Akrolein%D8%A7%DA%A9%D8%B1%D9%88%D9%84%DB%8C%D9%86%D0%90%D0%BA%D1%80%D0%B0%D0%BB%D0%B5%D1%96%D0%BDAcrole%C3%AFnaCategory:AcroleinAkroleinAcrolein%CE%A0%CF%81%CE%BF%CF%80%CE%B5%CE%BD%CE%AC%CE%BB%CE%B7AcroleinAkroleinoAcrole%C3%ADnaAkroleiin%D8%A7%DA%A9%D8%B1%D9%88%D9%84%DB%8C%D9%86AkroleiiniAcrol%C3%A9ineAcrole%C3%ADna%D7%90%D7%A7%D7%A8%D7%95%D7%9C%D7%99%D7%99%D7%9FAkrolein%D4%B1%D5%AF%D6%80%D5%B8%D5%AC%D5%A5%D5%AB%D5%B6AkroleinAcroleina%E3%82%A2%E3%82%AF%E3%83%AD%E3%83%AC%E3%82%A4%E3%83%B3%E1%83%90%E1%83%99%E1%83%A0%E1%83%9D%E1%83%9A%E1%83%94%E1%83%98%E1%83%9C%E1%83%98%D0%90%D0%BA%D1%80%D0%BE%D0%BB%D0%B5%D0%B8%D0%BD%D0%90%D0%BA%D1%80%D0%BE%D0%BB%D0%B5%D0%B8%D0%BDAkroleinasAkrole%C4%ABns%E0%B4%85%E0%B4%95%E0%B5%8D%E0%B4%B0%E0%B5%8B%E0%B4%B2%E0%B4%BF%E0%B5%BBAkroleinAcrole%C3%AFneAkroleinaAcrole%C3%ADnaAcrolein%C4%83%D0%90%D0%BA%D1%80%D0%BE%D0%BB%D0%B5%D0%B8%D0%BDAkroleinAkroleinAkroleinAkrolein%D0%90%D0%BA%D1%80%D0%BE%D0%BB%D0%B5%D0%B8%D0%BD
about
Failure of acrolein to produce sensitization in the guinea pig maximization testEvaluation of techniques for reducing diesel forklift emissionsEvaluation of a multiple sclerosis cluster among nurses in an inpatient oncology wardDetermination of acrolein in air as an oxazolidine derivative by gas chromatographyThe determination in air of selected low-molecular weight aldehydes as their oxazolidines by capillary gas chromatographySynergistic inactivation of plasma alpha1-proteinase inhibitor by aldehydes of cigarette smoke with styrene oxide and 1,2-dichloroethaneHuman erythrocyte glutathione s-transferase: A possible marker of chemical exposureEnvironmental study of firefightersRespirator canister evaluation for nine selected organic vaporsIn vitro covalent modification of serum albumin by acroleinQuantitation of blood protein adducts of acrolein by tritiated sodium borohydride reductionRapid plasma clearance of albumin-acrolein adduct in ratsInteractions of sulfur dioxide and acrolein as sensory irritants.Sensory irritation to formaldehyde and acrolein during single and repeated exposures in miceNonisocyanate exposures in three flexible polyurethane manufacturing facilitiesComparative toxicity of allylamine and acrolein in cultured myocytes and fibroblasts from neonatal rat heartIn vitro inactivation of glucose-6-phosphate dehydrogenase from human red blood cells by acrolein: a possible biomarker of exposure3-Hydroxypropylmercapturic acid: a biologic marker of exposure to allylic and related compoundsInhibition of rat heart mitochondrial electron transport in vitro: implications for the cardiotoxic action of allylamine or its primary metabolite, acrolein.Exposure to volatile organic compounds in healthcare settingsA new passive sampler for aldehydesVapor/solid chemisorption model for passive sampling of aldehydesMethod development study for APR cartridge evaluation in fire overhaul exposuresDose-response analysis in animal studies: prediction of human responsesHealth hazard evaluation report: HETA-2011-0047-3143, multiple sclerosis cluster evaluation in an inpatient oncology ward - WisconsinNotes from the field: acute pesticide-related illness resulting from occupational exposure to acrolein - Washington and California, 1993-2009Health hazard evaluation report: HETA-2001-0066-3019, Morton Plant Hospital, Dunedin, FloridaHealth hazard evaluation report: evaluation of chemical exposures during fire fighter training exercises involving smoke simulantHealth hazard evaluation Report: HETA-2003-0102-2921, Bemis, West Hazelton, PennsylvaniaHealth hazard evaluation report: HETA-2001-0030-3020, Carolinas Medical Center, Charlotte, North CarolinaEvaluating vehicle fire training inhalation hazardsHealth hazard evaluation report: HETA-2000-0402-3021, Inova Fairfax Hospital, Falls Church, VirginiaControl of Indoor Air ContaminantsQuantitation of acrolein and crotonaldehyde modified albuminChronic sulfur dioxide exposure in a smelter. I. Exposure to SO2 and dust: 1940-1974Alterations of barbiturate action following 1,1-dichloroethylene, corticosterone, or acroleinInactivation of plasma alpha1-proteinase inhibitor by acrolein: adduct formation with lysine and histidineInactivation of plasma alpha1-proteinase inhibitor by aldehydes found in cigarette smokeHHE Report No. HETA-86-284-1914, H.B. Smith Company, Inc., Westfield, MassachusettsHHE Report No. HETA-94-0309-2514, Homecrest Industries Incorporated, Wadena, Minnesota
P921
Q23909766-30CA9523-7166-43D2-B0A0-F7292D82C53AQ23911900-BC3923BB-84EB-4B2C-841D-960051B61843Q23912471-D4022946-EB49-417B-9C7C-A348F1931FA1Q23912678-879396F9-29D3-411B-975A-25C31D7817D4Q23912681-E95A2EB4-A2A1-4281-ACED-58C520D3CD35Q23912909-4358C1B2-45DA-4260-BB37-36362CF698C8Q23912912-141C50EE-DDAC-4C43-991D-711FB0268E90Q23913928-DC757246-9653-46AE-B91A-9FB182A3C8A5Q23914104-41E6FD4D-B30E-4D91-B15B-FFCFCCE05A26Q23915386-135AF5FF-6DA1-4A97-BBCA-0C51B5B42988Q23915783-DDA58DB1-8135-421A-8F4B-7407F476D80EQ23915897-BF4EA442-3DD9-465B-946E-5432EB0212F8Q23916746-D5ED3A11-77E0-4EAA-AE10-8FD111AAC690Q23916747-A16B3CD9-5266-4474-A188-328F7E753C02Q23917724-DC72EE5C-9E54-4B51-B7CD-A09589B9F9DBQ23917803-46407B80-025A-4C36-8CBF-A9428EDBF03CQ23918946-7530D1B4-240D-4DDE-BB28-BA31357849E1Q23919889-4E960ED8-26BD-452B-B6B1-EE6CFE2F2F2CQ23919985-4EEFD6AC-4E3C-440F-831C-0440377AC317Q23920650-2B513677-D59D-429D-91E5-F3AE15A9B575Q23921383-FB4A04B9-04BB-4A1D-B7D0-06D307012C17Q23921384-C4013EC9-8944-473E-8A45-B23F17B2684BQ23922259-96F55B8D-3788-4679-A96A-7FD0FE44F104Q23922905-CBCC207D-4E65-46C4-BBE0-A0606B348C15Q24266781-1A1D7A92-115C-4DDF-9B7E-DAB22EBD6FDDQ24584982-5CC4D13D-B0EE-4B87-A7B7-6E3689A9D5D3Q24704016-758BE6E3-55A9-42A0-8F64-ACE321D3DA6DQ24706597-75100854-F887-4823-A8FC-5C25CB166BE8Q24707018-9B592174-C460-45D4-A311-D560A1D6578CQ24825666-D8CE9CF2-D2DB-4D74-A3B4-66D92BB2A568Q25930197-0EA19DB0-1368-40D1-A5D0-198DA3481779Q26153336-7ACF17A0-AB9B-4D0F-9DEA-BB99D5DC14C6Q26272064-E6A526E4-2F42-4A96-AF60-13E46C95CD38Q26338858-59FA5C34-C101-4708-A3C6-333B81E75B09Q26340957-AFA3F126-A80C-4ECC-A7E6-FB1D30E02A0FQ26342889-E07217B6-CF9F-4287-879A-811ED905B429Q26343034-8C3410F1-BB71-4B8C-8989-E458FE4003B0Q26344262-06894929-57A4-4270-A52F-F6AEBE60AB05Q26346115-C12C116F-AFF8-4C44-BD11-247A7C117CA9Q26346363-39BF73C0-6FE9-4430-978E-5A5C231090A7
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische stof
@nl
component quimic
@oc
name
2-προπενάλη
@el
Acrolein
@de
Acrolein
@vi
Acroleină
@ro
Acroleína
@es
Acroleína
@gl
Acroleïne
@nl
Acroléine
@fr
Akroleiin
@et
Akroleiini
@fi
type
label
2-προπενάλη
@el
Acrolein
@de
Acrolein
@vi
Acroleină
@ro
Acroleína
@es
Acroleína
@gl
Acroleïne
@nl
Acroléine
@fr
Akroleiin
@et
Akroleiini
@fi
altLabel
107-02-8
@fr
2-Propen-1-one
@en
2-Propenal
@de
2-Propenal
@en
2-Propenaldehyde
@en
2-propenaal
@et
2-propenal
@es
Acquinite
@en
Acquinite
@fr
Acraldehyde
@en
prefLabel
2-προπενάλη
@el
Acrolein
@de
Acrolein
@vi
Acroleină
@ro
Acroleína
@es
Acroleína
@gl
Acroleïne
@nl
Acroléine
@fr
Akroleiin
@et
Akroleiini
@fi